BIIB
Biogen Inc.
$158.01
Earnings Summary
Revenue | $2465.8Mn |
Net Profits | $388.5Mn |
Net Profit Margins | 15.76% |
Highlights
Biogen Inc.’s revenue fell -2.55% since last year same period to $2465.8Mn in the Q3 2024. On a quarterly growth basis, Biogen Inc. has generated 4.79% jump in its revenue since last 3-months.
Biogen Inc.’s net profit jumped 670.48% since last year same period to $388.5Mn in the Q3 2024. On a quarterly growth basis, Biogen Inc. has generated -33.43% fall in its net profits since last 3-months.
Biogen Inc.’s net profit margin jumped 685.41% since last year same period to 15.76% in the Q3 2024. On a quarterly growth basis, Biogen Inc. has generated -36.48% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Biogen Inc. post its latest quarter earnings
EPS Estimate Current Quarter | 3.79 |
EPS Estimate Current Year | 3.79 |
Highlights
Biogen Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.79 - a -5.96% fall from last quarter’s estimates.
Biogen Inc.’s earning per share (EPS) estimates for the current year stand at 3.79.
Key Ratios
Key ratios of the Biogen Inc. post its Q3 2024 earnings
Earning Per Share (EPS) | 4.08 |
Highlights
Biogen Inc.’s earning per share (EPS) fell -6.42% since last year same period to 4.08 in the Q3 2024. This indicates that the Biogen Inc. has generated -6.42% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-01 | 4.03 | 5.28 | 31.02% |
2024-04-24 | 3.45 | 3.67 | 6.38% |
2024-10-30 | 3.79 | 4.08 | 7.65% |
₹0 US Stocks a/c Opening Fee